Medical Technology Company Announces Successful Assistance For Over 7,000 low-income Lupus Patients

In an era where medical aid is often a luxury for low-income individuals, Shanghai Zhongxin Medical Technology Co., Ltd., consolidated by Zhongchao Inc. (NASDAQ: ZCMD) ["Zhongchao"], stands out. They have successfully provided medication assistance services to over 7,000 low-income patients suffering from Systemic Lupus Erythematosus (SLE), significantly reducing their financial challenges associated with long-term treatment. $ZHONGCHAO(ZCMD.US)$